What does a calprotectin level of 94.3 indicate?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Interpretation of Calprotectin Level 94.3 μg/g

A calprotectin level of 94.3 μg/g falls in the mildly elevated range, suggesting possible intestinal inflammation that requires clinical correlation but is below the threshold for definitive inflammatory bowel disease diagnosis. 1, 2

Understanding Calprotectin Values

Fecal calprotectin is a surrogate marker of intestinal inflammation that correlates well with endoscopic inflammation in both ulcerative colitis and Crohn's disease. The British Society of Gastroenterology guidelines provide the following interpretive thresholds:

  • <50 μg/g: Normal/Negative (high negative predictive value for ruling out IBD)
  • 50-100 μg/g: Mildly elevated (borderline)
  • 100-250 μg/g: Intermediate elevation (consider referral to gastroenterology)
  • >250 μg/g: Significantly elevated (high specificity for active intestinal inflammation)

Clinical Significance of 94.3 μg/g

Your calprotectin level of 94.3 μg/g indicates:

  • It falls just below the intermediate range (100-250 μg/g) 1
  • Has higher sensitivity (>90%) but lower specificity for detecting intestinal inflammation 2
  • May represent mild inflammation but could also be a false positive 1, 2

Diagnostic Algorithm Based on Calprotectin Level

  1. For values <50 μg/g:

    • High negative predictive value for IBD (>90%)
    • Consider non-inflammatory conditions like IBS
  2. For values 50-100 μg/g (your result falls here):

    • Consider:
      • Mild IBD activity
      • Early IBD
      • Other causes of mild inflammation
    • Clinical correlation required
  3. For values 100-250 μg/g:

    • Moderate probability of IBD
    • Gastroenterology referral recommended
  4. For values >250 μg/g:

    • High specificity (82%) for active IBD 1, 2
    • Urgent gastroenterology referral indicated

Important Considerations

  • False positives: NSAID use within 6 weeks can falsely elevate calprotectin levels 2
  • Sample collection: First morning stool is recommended; samples should be analyzed within 3 days if kept at room temperature 1
  • Topographical gradient: Calprotectin levels increase from proximal to distal bowel segments for similar inflammatory activity 3
  • Differential diagnosis: Elevated levels can occur in:
    • Inflammatory bowel disease
    • Infectious enteritis
    • Colorectal cancer
    • Microscopic colitis 4

Next Steps Based on Your Result

  1. Clinical correlation:

    • Assess for symptoms (diarrhea, abdominal pain, rectal bleeding)
    • Review medication history (especially NSAIDs)
    • Evaluate for alarm symptoms (weight loss, anemia)
  2. If symptoms suggest possible IBD:

    • Consider repeat testing in 4-6 weeks
    • If symptoms persist or worsen, referral to gastroenterology is appropriate despite borderline value 2
  3. If no concerning symptoms:

    • Monitor clinically
    • Consider repeat testing if symptoms develop or worsen

Remember that calprotectin is a screening tool and not a definitive diagnostic test. The interpretation must always consider the clinical context and patient's symptoms.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnostic Evaluation of Gastrointestinal Pathology

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Fecal Calprotectin for the Diagnosis and Management of Inflammatory Bowel Diseases.

Clinical and translational gastroenterology, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.